These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 12072934)

  • 1. Promising role of 18-F-fluoro-D-deoxyglucose positron emission tomography in clinical infectious diseases.
    De Winter F; Vogelaers D; Gemmel F; Dierckx RA
    Eur J Clin Microbiol Infect Dis; 2002 Apr; 21(4):247-57. PubMed ID: 12072934
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fever of unknown origin: the role of 18F-FDG PET/CT.
    Keidar Z; Gurman-Balbir A; Gaitini D; Israel O
    J Nucl Med; 2008 Dec; 49(12):1980-5. PubMed ID: 18997040
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Value of (18)F-FDG-PET/CT in patients with fever of unknown origin and unexplained prolonged inflammatory syndrome: a single centre analysis experience.
    Federici L; Blondet C; Imperiale A; Sibilia J; Pasquali JL; Pflumio F; Goichot B; Blaison G; Weber JC; Christmann D; Constantinesco A; Andrès E
    Int J Clin Pract; 2010 Jan; 64(1):55-60. PubMed ID: 18479364
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Approach to fever of unknown origin: the role of positron-emission tomography].
    Poncini G; Nendaz M
    Rev Med Suisse; 2010 Feb; 6(234):249-53. PubMed ID: 20334084
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of positron emission tomography with methyl-11C-choline and 2-18F-fluoro-2-deoxy-D-glucose in comparison with magnetic resonance imaging for the assessment of inflammatory proliferation of synovium.
    Roivainen A; Parkkola R; Yli-Kerttula T; Lehikoinen P; Viljanen T; Möttönen T; Nuutila P; Minn H
    Arthritis Rheum; 2003 Nov; 48(11):3077-84. PubMed ID: 14613269
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PET/CT in musculoskeletal infection.
    Strobel K; Stumpe KD
    Semin Musculoskelet Radiol; 2007 Dec; 11(4):353-64. PubMed ID: 18324599
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 18-fluorodeoxyglucose positron emission tomography enhances computed tomography diagnosis of malignant intraductal papillary mucinous neoplasms of the pancreas.
    Sperti C; Bissoli S; Pasquali C; Frison L; Liessi G; Chierichetti F; Pedrazzoli S
    Ann Surg; 2007 Dec; 246(6):932-7; discussion 937-9. PubMed ID: 18043094
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased (18)F-fluorodeoxyglucose uptake in benign, nonphysiologic lesions found on whole-body positron emission tomography/computed tomography (PET/CT): accumulated data from four years of experience with PET/CT.
    Metser U; Even-Sapir E
    Semin Nucl Med; 2007 May; 37(3):206-22. PubMed ID: 17418153
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of 18F-FDG PET or PET/CT in the detection of fever of unknown origin.
    Qiu L; Chen Y
    Eur J Radiol; 2012 Nov; 81(11):3524-9. PubMed ID: 22766321
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Whole-body imaging with PET/MRI.
    Gaa J; Rummeny EJ; Seemann MD
    Eur J Med Res; 2004 Jun; 9(6):309-12. PubMed ID: 15257872
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical use of FDG PET.
    Hoh CK
    Nucl Med Biol; 2007 Oct; 34(7):737-42. PubMed ID: 17921026
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The role of whole body 2-[fluorine-18]-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography in the management of unknown primary tumors].
    Wu ZJ; Zhang YX; Wei H; Jia Q
    Zhonghua Yi Xue Za Zhi; 2007 Aug; 87(32):2253-6. PubMed ID: 18001544
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Usefulness of whole body positron emission tomography (PET) with 18F-fluoro-2-deoxyglucose (FDG) to detect recurrent ovarian cancer based on asymptomatically elevated serum levels of tumor marker.
    Chang WC; Hung YC; Kao CH; Yen RF; Shen YY; Lin CC
    Neoplasma; 2002; 49(5):329-33. PubMed ID: 12458332
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical value of [(18)F]fluoro-deoxyglucose positron emission tomography for patients with fever of unknown origin.
    Blockmans D; Knockaert D; Maes A; De Caestecker J; Stroobants S; Bobbaers H; Mortelmans L
    Clin Infect Dis; 2001 Jan; 32(2):191-6. PubMed ID: 11170907
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 18F-FDG PET and PET/CT in fever of unknown origin.
    Meller J; Sahlmann CO; Scheel AK
    J Nucl Med; 2007 Jan; 48(1):35-45. PubMed ID: 17204697
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contribution of 18fluoro-deoxyglucose PET/CT for the diagnosis of infectious diseases.
    Revest M; Patrat-Delon S; Devillers A; Tattevin P; Michelet C
    Med Mal Infect; 2014 Jun; 44(6):251-60. PubMed ID: 24844599
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Applications of fluorodeoxyglucose positron emission tomography in the diagnosis of infection.
    Chacko TK; Zhuang H; Nakhoda KZ; Moussavian B; Alavi A
    Nucl Med Commun; 2003 Jun; 24(6):615-24. PubMed ID: 12766596
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of 18-fluoro-2-deoxyglucose positron emission tomography in detecting acute inflammatory lesions of non-bacterial osteitis in patients with a fever of unknown origin: A comparative study of 18-fluoro-2-deoxyglucose positron emission tomography, bone scan, and magnetic resonance imaging.
    Shimizu M; Saikawa Y; Yachie A
    Mod Rheumatol; 2018 Nov; 28(6):1058-1062. PubMed ID: 27321232
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical value of FDG PET in patients with fever of unknown origin and patients suspected of focal infection or inflammation.
    Bleeker-Rovers CP; de Kleijn EM; Corstens FH; van der Meer JW; Oyen WJ
    Eur J Nucl Med Mol Imaging; 2004 Jan; 31(1):29-37. PubMed ID: 14551752
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Febrile syndrome of unknown origin: Indications for
    García JR
    Radiologia; 2017; 59(3):253-263. PubMed ID: 27671947
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.